New data from the National Center for Health Statistics of Disease Control and Prevention suggests that American states saw the biggest decrease in overdose deaths between 2022 and 2023.
During that time, the deaths due to drug overdose declined by 4%, the first time after the deaths of overdose declined since the beginning of the first overdose deaths. Koronwirus epidemic in 2020The trend continued in 2024, with Overdose deaths fall 17% Between July 2023 and July 2024, CBS News stated earlier.
Between 2022 and 2023, the age-time rate of deaths from drug overdose in 20 states including New Jersey, Michigan, Kansas, Louisiana and Florida decreased “significantly”, which saw “significant decrease” during this window.
Six states – Alabama, Alaska, California, Nevada, Oregon and Washington – saw a “significant increase” in overdose deaths. The remaining 24 American states and Columbia district saw “non-mating” changes in overdose mortality.
The state with the highest rate of overdose deaths per 100,000 people was West Virginia, with 81.9 deaths per 100,000 people. Among the lowest -rate states were Nebraska, who had 9 deaths per 100,000 people, and South Dakota, including 11.2 deaths per 100,000 people.
The types of drugs found in overdose during this time period also changed. The decline in deaths including nationwide, synthetic opioid fentinel, falling, falls, while the deaths that incorporate psychostimulants with misconduct capacity like Menthafetamine, overdose.
Deaths related to opioid decreased In 20 states, and nine increased. Overdose, with synthetic opioids such as Phantenl, decreased in 17 states and increased in 11. Meanwhile, deaths associated with psychostimulant such as Menthafetamine fell into nine states and six rose. Overdose deaths related to cocaine declined in three states and 13 increased.
Experts have credited the reduction in the deaths of Opioids for more aggressive public health functions, including to provide opioid-reversal drug Naloxone at the counter, and attempts to expand access Drugs Opioid use disorder.
“We are encouraged by this data, but boy, it’s time to double the things we know that it is working. It’s not time to pull back, and I feel very strongly, And our data shows that the danger continues to develop, “Dr. Ellen Arwadi, Head of CDC National Center for Injury Prevention and Control, Told CBS News in November,
